Head, Bioanalysis, Biomarker Development and Diagnostics Bill and Melinda Gates Foundation Hingham, Massachusetts
If you are looking for current challenges in the field of bioanalytical assays look no further. This session will provide opportunities for scientists, managers, clinicians, regulatory scientists to learn about the bio analytical area of clinical vaccine development. The presentation will cover the differences in assay development for vaccines and biologics, detailed aspects of vaccine assays/methodologies, and case studies. The session will also describe unique opportunities and challenges for vaccine development.
understand the regulatory requirements for a vacine clinical assay to support licensure.
discuss the challenges and great opportunities for a scientist in developing vaccine clinical assays.
identify and explore new opportunities for vaccine clinical assay development.